"A monthly injection of an experimental drug made by the US biotech firm Amgen reduced patients' cholesterol by up to 66 percent, according to a small study described at a US cardiology conference. (AFP Photo/Cesar Manso)" title
View the Original article
No comments:
Post a Comment